CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-02). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1967 · Search date 2026-08-02 · Methodology v0.6

Yacon syrup,
does it really help with Post-meal satiety and appetite suppression?

30-Second Summary
D
Evidence Grade D · 30 · Safety caution
A prospectively registered acute trial found no difference in satiety or appetite hormones
Fourteen grams of fructooligosaccharides may cause gas, bloating, or diarrhea, so sensitive users may need a smaller amount.
What the
research shows
The grade is D with 30 points. In a prospectively registered randomized double-blind crossover trial, the primary endpoints, GLP-1 and ghrelin areas under the curve, were both null. Secondary hunger, satiety, fullness, and desire-to-eat ratings were also null. No 95% confidence intervals were reported, so the range of possible benefit remains unknown.
What the
ads claim
Containing a prebiotic carbohydrate is a composition fact, not proof of appetite suppression. The trial directly measured both appetite hormones and subjective appetite and found no difference.
*

Useful facts when choosing a product

  • The 40-g yacon-syrup dose contained 14 g of fructooligosaccharides.
  • Yacon is native to the Andes, and no record was confirmed in the surveyed Korean, Chinese, Japanese, Indian, Islamic, or Greco-Roman classical sources.
  • Verdict 021 is D with no recorded score for bitter melon, Jerusalem artichoke, and glucose. Yacon is a different plant, and this verdict addresses appetite.
Gap Measurement · Verdict 1967 · D 30
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The flow diagram shows 42 women starting and 40 completing and entering analysis, while the paper does not clearly distinguish randomized from started counts. Breakfast plus 40 g yacon syrup was compared with maltodextrin in a randomized double-blind crossover design. Ghrelin and GLP-1 areas under the curve and ratings of hunger, satiety, fullness, and desire to eat were all nonsignificant. Main 95% confidence intervals were not reported. Support came from FUNECE and the State University of Ceara, the Brazilian public agricultural institute Embrapa Agroindustria Tropical, and CAPES-related sources; this is not identified as manufacturer funding.

02

Why this is classified as D (30)

The prospectively registered primary GLP-1 and ghrelin areas under the curve and the secondary subjective appetite outcomes were all null in the direct randomized trial. Because it was a single small acute study with no confidence intervals, it does not exclude meaningful benefit and receives D with 30 points.

Counterpoint. The study addressed acute post-meal responses, not long-term food intake or weight change.

Rejudgment record. Cross-check applied — Prospectively registered primary GLP-1 and ghrelin areas under the curve and secondary subjective appetite outcomes were all null in a small acute crossover trial with no reported 95% confidence intervals

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Acute appetite suppression by yacon syrupDPrimary GLP-1 and ghrelin and secondary subjective appetite outcomes were all nonsignificant.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Double-blind randomized crossover single-meal trial40Brazilian university, public agricultural institute, and CAPES-related supportPrimary GLP-1 and ghrelin AUCs; secondary subjective appetitePrimary hormone and secondary subjective appetite outcomes all null; no 95% CIs reportedDirect prospectively registered randomized null result
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-02).

Adriano LS, Dionisio AP, et al. Acute postprandial effect of yacon syrup ingestion on appetite: a double blind randomized crossover clinical trial. Food Res Int. 2020;137:109648. PMID: 33233227. DOI: 10.1016/j.foodres.2020.109648.
checked
Brazilian Registry of Clinical Trials. RBR-33wf46.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none

Cite this verdict

Yacon syrup x post-meal satiety and appetite suppression Evidence Grade D card
[Chamgap] Yacon syrup x post-meal satiety and appetite suppression — Evidence Grade D·30. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/weight/yacon-syrup-postprandial-satiety-appetite-suppression/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.